Israeli biotech startup Mana.bio has been planning to launch its programmable drug treatment solution for months, and decided to forge ahead in spite of the attacks that happened this past weekend in the country. The company is using an AI-driven approach called liquid nanoparticles (LNP) to create unique programmable drug treatments. “Mana.bio’s integrated experimental and […] Read more: Read More
Blogs and news from the borders of America.
